References

1. Bates S.Fairfax man accused of anthrax threat.Washington Post.March 3, 1992;C.

2. Breman JG, Henderson DA.Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism.N Engl J Med.Aug 201998;339(8):556-9.[Medline].

3. CDC.Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998.MMWR Morb Mortal Wkly Rep.Feb 51999;48(4):69-74.[Medline].

4. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM.Biological warfare. A historical perspective.JAMA.Aug 61997;278(5):412-7.[Medline].

5. Danzig R, Berkowsky PB.Why should we be concerned about biological warfare?.JAMA.Aug 61997;278(5):431-2.[Medline].

6. Dixon TC, Meselson M, Guillemin J, Hanna PC.Anthrax.N Engl J Med.Sep 91999;341(11):815-26.[Medline].

7. Ferguson JR.Biological weapons and US law.JAMA.Aug 61997;278(5):357-60.[Medline].

8. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR.Clinical recognition and management of patients exposed to biological warfare agents.JAMA.Aug 61997;278(5):399-411.[Medline].

9. Harteveld JL, Nieuwenhuizen MS, Wils ER.Detection of staphylococcal enterotoxin B employing a piezoelectric crystal immunosensor.Biosens Bioelectron.1997;12(7):661-7.[Medline].

10. Headquarters, Department of the Army.Treatment of Biological Warfare Agent Casualties.Washington, DC:Dept of the Army;July 2000.

11. Henderson DA.The looming threat of bioterrorism.Science.Feb 261999;283(5406):1279-82.[Medline].

12. Holloway HC, Norwood AE, Fullerton CS, Engel CC, Ursano RJ.The threat of biological weapons. Prophylaxis and mitigation of psychological and social consequences.JAMA.Aug 61997;278(5):425-7.[Medline].

13. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM.Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.JAMA.May 121999;281(18):1735-45.[Medline].

14. Kadlec RP, Zelicoff AP, Vrtis AM.Biological weapons control. Prospects and implications for the future.JAMA.Aug 61997;278(5):351-6.[Medline].

15. Kaufmann AF, Meltzer MI, Schmid GP.The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?.Emerg Infect Dis.Apr-Jun1997;3(2):83-94.[Medline].

16. Keim M, Kaufmann AF.Principles for emergency response to bioterrorism.Ann Emerg Med.Aug1999;34(2):177-82.[Medline].

17. Lebeda FJ.Deterrence of biological and chemical warfare: a review of policy options.Mil Med.Mar1997;162(3):156-61.[Medline].

18. Lederberg J.Infectious disease and biological weapons. Prophylaxis and mitigation.JAMA.Aug 61997;278(5):435-6.[Medline].

19. McGovern TW, Christopher GW, Eitzen EM.Cutaneous manifestations of biological warfare and related threat agents.Arch Dermatol.Mar1999;135(3):311-22.[Medline].

20. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A.The Sverdlovsk anthrax outbreak of 1979.Science.Nov 181994;266(5188):1202-8.[Medline].

21. Mobley JA.Biological warfare in the twentieth century: lessons from the past, challenges for the future.Mil Med.Nov1995;160(11):547-53.[Medline].

22. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumada K.Report on 640 victims of the Tokyo subway sarin attack.Ann Emerg Med.Aug1996;28(2):129-35.[Medline].

23. Pearson GS.The complementary role of environmental and security biological control regimes in the 21st century.JAMA.Aug 61997;278(5):369-72.[Medline].

24. Pesik N, Keim M, Sampson TR.Do US emergency medicine residency programs provide adequate training for bioterrorism?.Ann Emerg Med.Aug1999;34(2):173-6.[Medline].

25. Pile JC, Malone JD, Eitzen EM, Friedlander AM.Anthrax as a potential biological warfare agent.Arch Intern Med.Mar 91998;158(5):429-34.[Medline].

26. Richards CF, Burstein JL, Waeckerle JF, Hutson HR.Emergency physicians and biological terrorism.Ann Emerg Med.Aug1999;34(2):183-90.[Medline].

27. Robertson AG, Robertson LJ.From asps to allegations: biological warfare in history.Mil Med.Aug1995;160(8):369-73.[Medline].

28. Sidell FR, Takafuji ET, Franz DR.Textbook of Military Medicine. Part I: Warfare, Weaponry, and the Casualty: Medical Aspects of Chemical and Biological Warfare.Washington, DC:TMM Publications, Borden Institute.

29. Stephenson J.Pentagon-funded research takes aim at agents of biological warfare.JAMA.Aug 61997;278(5):373-5.[Medline].

30. Tucker JB.National health and medical services response to incidents of chemical and biological terrorism.JAMA.Aug 61997;278(5):362-8.[Medline].

31. Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S.A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars.JAMA.Aug 61997;278(5):389-95.[Medline].

32. US Army Medical Research Institute of Infectious Disease.Medical Management of Biological Casualties Handbook.4^th ed.Frederick, Md: Fort Detrick:2000.

33. Wiener SL.Strategies for the prevention of a successful biological warfare aerosol attack.Mil Med.May1996;161(5):251-6.[Medline].

34. Zajtchuk R, Bellamy RD, eds.Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Part 1.Washington, DC:Office of the Surgeon General;1997.

35. Zydowicz D.Anthrax: a disease from antiquity visits the modern world.Minn Med.Jul1998;81(7):19-20.[Medline].